Giulia Cattaneo
University of Pavia
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Giulia Cattaneo.
Journal of Chromatography B | 2014
Enrica Calleri; Daniela Ubiali; Immacolata Serra; Caterina Temporini; Giulia Cattaneo; Giovanna Speranza; Carlo F. Morelli; Gabriella Massolini
We described the development of a biochromatographic system which uses a purine nucleoside phosphorylase from Aeromonas hydrophila (AhPNP) for the evaluation of the substrate specificity on nucleoside libraries. AhPNP has been covalently immobilized on a fused silica Open Tubular Capillary (OTC) via Schiff base chemistry. The resulting bioreactor has been characterized by the determination of kinetic constants (Km and Vmax) for a natural substrate (inosine) and then assayed versus all natural purine (deoxy)ribonucleosides and a small library of 6-substituted purine ribosides. Characterization of the bioreactor has been carried out through a bidimensional chromatographic system with the sample on-line transfer from the bioreactor to the analytical column for the separation and quantification of substrate and product. Comparison with the soluble enzyme showed that the AhPNP-based bioreactor is reliable as the same ranking order, with respect to the standard activity assay, was obtained. The stability of the IMER was also assessed and the system was found to be stable up to 60 reactions.
Scientific Reports | 2017
Gloria Brusotti; Roberta Montanari; Davide Capelli; Giulia Cattaneo; Antonio Laghezza; Paolo Tortorella; Fulvio Loiodice; Franck Peiretti; Bernadette Bonardo; Alessandro Paiardini; Enrica Calleri; Giorgio Pochetti
PPAR antagonists are ligands that bind their receptor with high affinity without transactivation activity. Recently, they have been demonstrated to maintain insulin-sensitizing and antidiabetic properties, and they serve as an alternative treatment for metabolic diseases. In this work, an affinity-based bioassay was found to be effective for selecting PPAR ligands from the dried extract of an African plant (Diospyros bipindensis). Among the ligands, we identified betulinic acid (BA), a compound already known for its anti-inflammatory, anti-tumour and antidiabetic properties, as a PPARγ and PPARα antagonist. Cell differentiation assays showed that BA inhibits adipogenesis and promotes osteogenesis; either down-regulates or does not affect the expression of a series of adipogenic markers; and up-regulates the expression of osteogenic markers. Moreover, BA increases basal glucose uptake in 3T3-L1 adipocytes. The crystal structure of the complex of BA with PPARγ sheds light, at the molecular level, on the mechanism by which BA antagonizes PPARγ, and indicates a unique binding mode of this antagonist type. The results of this study show that the natural compound BA could be an interesting and safe candidate for the treatment of type 2 diabetes and bone diseases.
Chemcatchem | 2017
Giulia Cattaneo; Marco Rabuffetti; G. Speranza; Tom Kupfer; Benjamin Peters; Gabriella Massolini; Daniela Ubiali; Enrica Calleri
Uridine phosphorylase from Clostridium perfringens (CpUP, EC 2.4.2.3) was immobilized covalently in an aminopropylsilica monolithic column (25 mm×4.6 mm) upon functionalization with glutaraldehyde. Imino bonds that result from the reaction between the enzyme and the support were reduced chemically to afford a 66 % yield (13 mg) determined spectrophotometrically. The CpUP immobilized enzyme reactor (IMER) was connected to a silica particle‐based IMER that contained a purine nucleoside phosphorylase from Aeromonas hydrophila (AhPNP, EC 2.4.2.1), which was developed previously and used successfully for the fast synthesis of some purine ribonucleosides by a “one‐enzyme” transglycosylation. CpUP‐IMER and AhPNP‐IMER were connected to a HPLC system by a six‐way switching valve. In this set‐up, the synthesis of 2′‐deoxyadenosine (dAdo, 8), adenosine (Ado, 9), and arabinosyladenine (araA, 10) by a “two‐enzyme” transglycosylation is coupled directly to on‐line reaction monitoring. Under the optimized transglycosylation conditions (2:1 ratio sugar donor/base acceptor; 10 mm phosphate buffer; pH 7.25; temperature 37 °C, flow rate 0.1 mL min−1), defined by a 2(5‐2)III experimental design, the conversion of dAdo and Ado was approximately 90 %, and araA was synthesized in 20 % yield.
Advanced Synthesis & Catalysis | 2015
Enrica Calleri; Giulia Cattaneo; Marco Rabuffetti; Immacolata Serra; Teodora Bavaro; Gabriella Massolini; Giovanna Speranza; Daniela Ubiali
Molecules | 2016
Teodora Bavaro; Giulia Cattaneo; Immacolata Serra; Ilaria Benucci; Massimo Pregnolato; Marco Terreni
Current Organic Chemistry | 2015
Daniela Ubiali; Carlo F. Morelli; Marco Rabuffetti; Giulia Cattaneo; Immacolata Serra; Teodora Bavaro; Alessandra M. Albertini; Giovanna Speranza
Analytica Chimica Acta | 2016
Giulia Cattaneo; Daniela Ubiali; Enrica Calleri; Marco Rabuffetti; Georg Höfner; Klaus T. Wanner; Marcela Cristina de Moraes; Leonardo Kras Borges Martinelli; Diógenes Santiago Santos; Giovanna Speranza; Gabriella Massolini
XV Convegno-Scuola sulla Chimica dei Carboidrati | 2016
Alessandra M. Albertini; Teodora Bavaro; Enrica Calleri; Giulia Cattaneo; Gabriella Massolini; Marco Rabuffetti; Immacolata Serra; G. Speranza; Marco Terreni; Daniela Ubiali
SIMCC 2015 - Spanish-Italian Medicinal Chemistry Congress | 2015
Daniela Ubiali; Marina S. Robescu; Alba Fresco Taboada; Giulia Cattaneo; Teodora Bavaro; Jure Piškur; Louise Slot Christiansen; Andrés R. Alcántara; Marco Terreni; Immacolata Serra
Nuove Prospettive in Chimica Farmaceutica 8" (NPCF8) | 2014
Giulia Cattaneo; Enrica Calleri; Immacolata Serra; Carlo F. Morelli; Marco Rabuffetti; G. Speranza; Gabriella Massolini; Daniela Ubiali